Cephalalgia · 1992 · 50 citations · 17 references
MedicinePharmacologyPharmacotherapyNeuropharmacologyPain MedicinePsychopharmacologyAnalgesiaAnalgesic PharmacologyHeadache DisordersHeadache ManagementMigraine PharmacotherapySerotonergic Pharmacology5-Hydroxytryptamine 1A Receptor Agonists5-Hydroxytryptamine Receptor PharmacologyAnalgesic Use In HeadacheChronic HeadacheHeadache PathophysiologyMigraine Pharmacology
Subcutaneous treatment of chronic tension-type headache with 2 mg and 4 mg sumatriptan, a selective 5-hydroxytryptamine1-like receptor agonist, was compared with placebo in a double-blind crossover study of 36 patients. The effect was evaluated using a 6-point verbal relief rating scale and by visual analog scale ratings of headache intensity before and for 2 h after treatment. Sumatriptan induced a modest but significantly greater headache relief than placebo, whereas no significant difference was found between the two doses of sumatriptan. Headache relief following sumatriptan was significant after 60 min and still seemed to be increasing after 120 min when the examination terminated. Three possible mechanisms of action of sumatriptan in tension-type headache are discussed.
17
F Sorge, Roberto De Simone, Enrico Marano et al. · Cephalalgia · 1988 · 3.5K citations
Treatment of Acute Cluster Headache with Sumatriptan
New England Journal of Medicine · 1991 · 429 citations · Full text
Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan
Lars Friberg, B Sperling, Jes Olesen et al. · The Lancet · 1991 · 373 citations
Medicine, Neurology, Neurosurgery +14
Treatment of Acute Migraine With Subcutaneous Sumatriptan
Roger Cady · JAMA · 1991 · 314 citations